Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $8.98 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.79.
Market Cap
8.98T
Revenue
4.59T
Profits
200.61B
PE Ratio
44.79
Profit Margin
4.37%
Dividend Yield
0.39%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 0.67% | 1,640,214 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 600.99B | 1.07% | 6,088,465 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 445.46B | 3.29% | 3,179,015 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 384.53B | 1.17% | 10,529,102 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 315.84B | 3.45% | 5,612,602 | 65.77B |
| 6 | NVS | Novartis AG | 276.90B | 1.22% | 1,875,130 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 262.88B | 0.36% | 1,939,712 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 228.19B | 1.55% | 7,057,287 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 199.55B | 0.32% | 1,085,918 | 45.20B |
| 10 | AMGN | Amgen Inc. | 198.97B | 2.89% | 989,219 | 37.22B |
| 11 | ABT | Abbott Laboratories | 171.45B | 10.26% | 23,044,851 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 168.57B | 3.09% | 3,801,418 | 29.74B |
| 13 | DHR | Danaher Corporation | 143.41B | 0.91% | 2,592,773 | 24.78B |
| 14 | PFE | Pfizer Inc. | 142.83B | 0.97% | 30,623,553 | 63.32B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.66B | 2.83% | 3,202,792 | 10.58B |
| 16 | CVS | CVS Health Corporation | 135.39B | 0.19% | 5,377,146 | 405.62B |
| 17 | SYK | Stryker Corporation | 126.24B | 4.06% | 1,396,751 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 122.99B | 2.57% | 5,319,622 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 122.59B | 1.24% | 683,774 | 12.22B |
| 20 | MDT | Medtronic plc | 106.53B | 3.42% | 6,444,275 | 36.36B |
| 21 | SNY | Sanofi | 105.65B | 0.82% | 2,024,734 | 54.60B |
| 22 | GSK | GSK plc | 102.95B | 2.25% | 2,440,628 | 43.29B |
| 23 | MCK | McKesson Corporation | 98.58B | 5.73% | 753,606 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 85.36B | 1.57% | 1,183,861 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 81.06B | -4.37% | 1,880,686 | 201.11B |
| 26 | CI | The Cigna Group | 74.88B | -4.95% | 2,017,562 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 68.81B | 1.80% | 353,776 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.34B | 3.69% | 12,788,057 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.82B | 3.67% | 935,368 | 328.68B |
| 30 | MDLN | Medline Inc. | 54.02B | 4.26% | 3,993,584 | 29.14B |
| 31 | ARGX | argenx SE | 53.69B | -0.64% | 144,182 | 4.74B |
| 32 | CAH | Cardinal Health, Inc. | 53.66B | 1.85% | 1,190,214 | 250.74B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 52.09B | 1.58% | 5,016,938 | 28.34B |
| 34 | EW | Edwards Lifesciences Corporation | 50.42B | 0.34% | 3,849,638 | 6.30B |
| 35 | HUM | Humana Inc. | 46.98B | -4.04% | 1,290,069 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.59B | 3.76% | 344,397 | 4.45B |
| 37 | HLN | Haleon plc | 43.95B | 3.49% | 9,633,255 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 43.65B | 2.27% | 900,099 | 22.23B |
| 39 | NTRA | Natera, Inc. | 38.96B | -1.91% | 483,126 | 2.50B |
| 40 | A | Agilent Technologies, Inc. | 38.05B | 0.02% | 816,382 | 7.23B |
| 41 | RVMD | Revolution Medicines, Inc. | 37.70B | -3.85% | 1,023,451 | - |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.47B | 0.55% | 924,005 | 4.29B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 37.35B | 1.65% | 2,416,122 | 17.35B |
| 44 | WAT | Waters Corporation | 36.81B | -0.01% | 393,721 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 35.21B | 1.74% | 465,667 | 5.74B |
| 46 | IQV | IQVIA Holdings Inc. | 35.06B | 1.58% | 592,324 | 16.63B |
| 47 | RPRX | Royalty Pharma plc | 33.62B | 3.68% | 2,045,875 | 2.44B |
| 48 | ALC | Alcon Inc. | 33.48B | 3.05% | 934,383 | 10.63B |
| 49 | ZTS | Zoetis Inc. | 32.38B | 3.64% | 5,040,283 | 9.53B |
| 50 | VEEV | Veeva Systems Inc. | 32.09B | 2.00% | 904,036 | 3.32B |
| 51 | CNC | Centene Corporation | 31.94B | -2.90% | 2,416,927 | 178.33B |
| 52 | BIIB | Biogen Inc. | 30.75B | 5.61% | 1,063,859 | 9.94B |
| 53 | DXCM | DexCom, Inc. | 29.78B | 6.11% | 4,164,391 | 4.82B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 29.55B | 2.77% | 3,856,249 | 20.98B |
| 55 | RMD | ResMed Inc. | 29.10B | 1.59% | 554,649 | 5.54B |
| 56 | ILMN | Illumina, Inc. | 28.58B | 0.93% | 673,276 | 4.39B |
| 57 | MTD | Mettler-Toledo International Inc. | 26.87B | 0.99% | 52,702 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.98B | 0.85% | 719,774 | 20.34B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.52B | 0.61% | 248,858 | 3.22B |
| 60 | MRNA | Moderna, Inc. | 25.25B | -6.81% | 3,763,055 | 2.23B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.32B | -3.10% | 2,403,673 | 8.26M |
| 62 | INSM | Insmed Incorporated | 23.22B | -2.43% | 1,746,315 | 819.56M |
| 63 | INCY | Incyte Corporation | 23.17B | 0.77% | 743,301 | 5.36B |
| 64 | BNTX | BioNTech SE | 23.14B | -0.54% | 388,238 | 3.23B |
| 65 | DGX | Quest Diagnostics Incorporated | 23.00B | 2.96% | 484,895 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 22.92B | 2.78% | 251,459 | 14.14B |
| 67 | UTHR | United Therapeutics Corporation | 22.43B | -0.61% | 194,127 | 3.17B |
| 68 | STE | STERIS plc | 21.38B | 3.74% | 305,314 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 20.83B | -3.58% | 1,519,107 | 1.08B |
| 70 | VTRS | Viatris Inc. | 20.20B | 4.02% | 4,993,344 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 18.00B | 3.24% | 1,446,922 | 8.41B |
| 72 | GMAB | Genmab A/S | 17.76B | -0.72% | 1,173,300 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.29B | -0.03% | 569,263 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 17.06B | 2.96% | 709,673 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.31B | -2.25% | 211,096 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 15.84B | -2.24% | 2,318,877 | 579.96M |
| 77 | MEDP | Medpace Holdings, Inc. | 15.29B | 1.13% | 152,810 | 2.68B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 15.21B | 1.20% | 163,101 | 4.44B |
| 79 | DVA | DaVita Inc. | 15.08B | 1.40% | 240,428 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.47B | 1.73% | 3,115,777 | 13.65B |
| 81 | COO | The Cooper Companies, Inc. | 14.19B | 3.09% | 1,056,892 | 4.23B |
| 82 | SOLV | Solventum Corporation | 13.99B | 3.05% | 687,218 | 8.26B |
| 83 | EXEL | Exelixis, Inc. | 13.94B | -0.14% | 1,045,955 | 2.38B |
| 84 | SNN | Smith & Nephew plc | 13.07B | 2.05% | 2,213,447 | 6.16B |
| 85 | ICLR | ICON Public Limited Company | 12.98B | -1.54% | 280,710 | 8.27B |
| 86 | ELAN | Elanco Animal Health Incorporated | 12.93B | 1.39% | 2,357,215 | 4.89B |
| 87 | FMS | Fresenius Medical Care AG | 12.80B | 0.56% | 562,468 | 22.32B |
| 88 | ALGN | Align Technology, Inc. | 12.72B | -1.99% | 505,232 | 4.10B |
| 89 | PEN | Penumbra, Inc. | 12.55B | 0.74% | 373,576 | 1.45B |
| 90 | RVTY | Revvity, Inc. | 12.38B | -0.35% | 552,514 | 2.90B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.33B | -2.77% | 134,604 | 1.13B |
| 92 | AXSM | Axsome Therapeutics, Inc. | 12.10B | -1.03% | 306,915 | 708.24M |
| 93 | BAX | Baxter International Inc. | 11.95B | 4.45% | 4,412,330 | 11.32B |
| 94 | MOH | Molina Healthcare, Inc. | 11.82B | -2.73% | 589,344 | 43.10B |
| 95 | ABVX | ABIVAX Société Anonyme | 11.81B | -1.41% | 977,348 | 5.67M |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.55B | 1.37% | 588,567 | 3.24B |
| 97 | PODD | Insulet Corporation | 11.45B | 3.82% | 848,380 | 2.90B |
| 98 | TECH | Bio-Techne Corporation | 11.18B | 0.35% | 2,255,035 | 1.21B |
| 99 | EHC | Encompass Health Corporation | 11.15B | 2.30% | 370,863 | 6.07B |
| 100 | GMED | Globus Medical, Inc. | 10.98B | 3.00% | 1,338,628 | 3.10B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.91B | -2.78% | 756,013 | 105.82M |
| 102 | CRL | Charles River Laboratories International, Inc. | 10.90B | -0.88% | 399,366 | 4.03B |
| 103 | SMMT | Summit Therapeutics Inc. | 10.73B | -8.29% | 2,038,443 | - |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.59B | -0.16% | 1,144,329 | 3.58B |
| 105 | HSIC | Henry Schein, Inc. | 10.07B | 1.39% | 519,156 | 13.38B |
| 106 | ENSG | The Ensign Group, Inc. | 10.06B | 3.69% | 304,301 | 5.27B |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.04B | -0.21% | 912,278 | - |
| 108 | KRYS | Krystal Biotech, Inc. | 10.02B | -2.93% | 139,612 | 417.30M |
| 109 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.95B | -1.67% | 1,585,880 | 622.01M |
| 110 | NUVL | Nuvalent, Inc. | 9.83B | -0.01% | - | - |
| 111 | CORT | Corcept Therapeutics Incorporated | 9.72B | 1.11% | 424,806 | 769.10M |
| 112 | TEM | Tempus AI, Inc. | 9.54B | -7.21% | 3,328,655 | 1.36B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.32B | -0.74% | 426,215 | 51.48M |
| 114 | UHS | Universal Health Services, Inc. | 9.30B | 3.78% | 511,540 | 17.76B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 9.19B | 2.20% | 1,097,634 | 1.51B |
| 116 | GKOS | Glaukos Corporation | 9.17B | -0.41% | 383,574 | 551.35M |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 8.96B | -0.93% | 2,720,365 | 1.06B |
| 118 | BRKR | Bruker Corporation | 8.86B | -0.80% | 825,214 | 3.46B |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | -0.04% | 2,459,963 | 18.07M |
| 120 | ALKS | Alkermes plc | 8.71B | 0.52% | 1,118,593 | 1.56B |
| 121 | OSCR | Oscar Health, Inc. | 8.66B | -6.11% | 2,952,955 | 13.30B |
| 122 | ATR | AptarGroup, Inc. | 8.60B | 4.34% | 264,955 | 3.87B |
| 123 | QGEN | Qiagen N.V. | 8.55B | 0.22% | 1,307,153 | 2.10B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.52B | -2.25% | 249,583 | 74.06M |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 8.48B | -4.47% | 251,240 | 7.46M |
| 126 | SYRE | Spyre Therapeutics, Inc. | 8.37B | -6.79% | 831,208 | - |
| 127 | RGEN | Repligen Corporation | 8.36B | 0.14% | 425,133 | 763.34M |
| 128 | HQY | HealthEquity, Inc. | 8.22B | 3.45% | 529,775 | 1.34B |
| 129 | BIO | Bio-Rad Laboratories, Inc. | 8.03B | 1.48% | 126,168 | 2.59B |
| 130 | PCVX | Vaxcyte, Inc. | 7.99B | -2.54% | 529,509 | - |
| 131 | IMVT | Immunovant, Inc. | 7.95B | -2.86% | 504,877 | - |
| 132 | HIMS | Hims & Hers Health, Inc. | 7.89B | -8.29% | 9,693,628 | 2.37B |
| 133 | TGTX | TG Therapeutics, Inc. | 7.79B | -2.50% | 1,326,710 | 700.35M |
| 134 | IBRX | ImmunityBio, Inc. | 7.71B | -4.72% | 4,788,075 | 140.98M |
| 135 | AVTR | Avantor, Inc. | 7.63B | -0.18% | 8,302,260 | 6.55B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | -3.11% | 328,961 | 217.17M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 7.19B | -2.50% | 185,754 | 569.61M |
| 138 | PACS | PACS Group, Inc. | 7.18B | 0.76% | 504,850 | 5.43B |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.83B | 0.58% | 258,814 | 1.55B |
| 140 | HNGE | Hinge Health, Inc. | 6.63B | -0.08% | 740,568 | 646.34M |
| 141 | CHE | Chemed Corporation | 6.63B | 1.79% | 59,792 | 2.54B |
| 142 | LQDA | Liquidia Corporation | 6.61B | -4.46% | 719,501 | 288.07M |
| 143 | PTCT | PTC Therapeutics, Inc. | 6.49B | -0.75% | 379,243 | 827.11M |
| 144 | COGT | Cogent Biosciences, Inc. | 6.43B | -4.33% | 1,762,939 | - |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.38B | -2.53% | 984,076 | 7.50M |
| 146 | GRFS | Grifols, S.A. | 6.22B | 2.57% | 515,507 | 8.58B |
| 147 | SRRK | Scholar Rock Holding Corporation | 6.15B | -4.96% | 699,278 | - |
| 148 | CGON | CG Oncology, Inc. | 6.14B | -4.58% | 622,979 | 5.07M |
| 149 | TFX | Teleflex Incorporated | 6.02B | 3.29% | 301,818 | 2.13B |
| 150 | BLCO | Bausch + Lomb Corporation | 5.95B | 2.58% | 311,438 | 5.21B |
| 151 | ERAS | Erasca, Inc. | 5.91B | -10.58% | 4,564,812 | - |
| 152 | BLTE | Belite Bio, Inc | 5.90B | 0.31% | 77,672 | - |
| 153 | BLLN | BillionToOne, Inc. | 5.89B | -1.47% | 489,669 | 354.54M |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 5.86B | -0.14% | 133,812 | 274.48M |
| 155 | DFTX | Definium Therapeutics, Inc. | 5.78B | -4.62% | 2,764,246 | - |
| 156 | AMRX | Amneal Pharmaceuticals, Inc. | 5.72B | 4.33% | 1,469,767 | 3.05B |
| 157 | TWST | Twist Bioscience Corporation | 5.60B | -2.98% | 1,182,155 | 409.48M |
| 158 | STVN | Stevanato Group S.p.A. | 5.49B | 6.35% | 156,793 | 1.39B |
| 159 | TXG | 10x Genomics, Inc. | 5.41B | -6.78% | 2,839,715 | 638.78M |
| 160 | SHC | Sotera Health Company | 5.19B | 0.19% | 1,024,528 | 1.19B |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 5.15B | -5.80% | 747,954 | 1.34M |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.12B | -3.00% | 950,518 | 536.20M |
| 163 | ORKA | Oruka Therapeutics, Inc. | 5.02B | -3.95% | 309,571 | - |
| 164 | RDNT | RadNet, Inc. | 5.01B | 3.83% | 296,974 | 2.14B |
| 165 | INDV | Indivior Pharmaceuticals, Inc. | 4.94B | -0.95% | 986,968 | 1.29B |
| 166 | CRSP | CRISPR Therapeutics AG | 4.75B | -6.17% | 1,473,530 | 4.10M |
| 167 | CAI | Caris Life Sciences, Inc. | 4.67B | -5.33% | 1,940,524 | 907.29M |
| 168 | VCYT | Veracyte, Inc. | 4.66B | -1.90% | 466,435 | 541.74M |
| 169 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.64B | -2.16% | 212,707 | 754.05M |
| 170 | MANE | Veradermics, Incorporated | 4.52B | -12.49% | 1,044,276 | - |
| 171 | MMSI | Merit Medical Systems, Inc. | 4.51B | 3.50% | 399,931 | 1.54B |
| 172 | LIVN | LivaNova PLC | 4.48B | 2.69% | 300,176 | 1.43B |
| 173 | WAY | Waystar Holding Corp. | 4.47B | 2.78% | 953,054 | 1.16B |
| 174 | MMED | MiniMed Group, Inc. | 4.41B | 1.78% | 1,047,178 | 3.10B |
| 175 | NVST | Envista Holdings Corporation | 4.40B | 1.31% | 1,369,011 | 2.81B |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.38B | -1.37% | 1,379,373 | 1.10B |
| 177 | LFST | LifeStance Health Group, Inc. | 4.34B | 2.10% | 3,881,676 | 1.49B |
| 178 | CELC | Celcuity Inc. | 4.32B | -3.29% | 1,837,514 | - |
| 179 | LEGN | Legend Biotech Corporation | 4.31B | -3.21% | 2,433,605 | 1.14B |
| 180 | ALHC | Alignment Healthcare, Inc. | 4.24B | -2.01% | 1,766,064 | 4.26B |
| 181 | VKTX | Viking Therapeutics, Inc. | 4.19B | -4.60% | 1,039,684 | - |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.16B | -2.10% | 2,624,082 | 10.68M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 4.12B | -6.20% | 313,308 | - |
| 184 | DOCS | Doximity, Inc. | 4.08B | 0.13% | 796,166 | 644.86M |
| 185 | CON | Concentra Group Holdings Parent, Inc. | 4.07B | 3.99% | 472,458 | 2.23B |
| 186 | ICUI | ICU Medical, Inc. | 4.04B | 2.29% | 184,118 | 2.16B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.94B | -9.88% | 2,857,806 | 56.99M |
| 188 | IRTC | iRhythm Holdings, Inc. | 3.81B | 2.41% | 283,023 | 787.85M |
| 189 | DYN | Dyne Therapeutics, Inc. | 3.72B | -6.21% | 1,073,952 | - |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.71B | -4.12% | 32,979 | 803.79M |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.70B | -2.98% | 321,492 | - |
| 192 | NAMS | NewAmsterdam Pharma Company N.V. | 3.67B | -1.78% | 697,000 | 22.57M |
| 193 | BKD | Brookdale Senior Living Inc. | 3.60B | 5.24% | 5,291,726 | 3.00B |
| 194 | DNLI | Denali Therapeutics Inc. | 3.57B | -2.26% | 1,350,088 | - |
| 195 | HAE | Haemonetics Corporation | 3.55B | 1.88% | 552,328 | 1.33B |
| 196 | OGN | Organon & Co. | 3.55B | 0.11% | 1,288,971 | 6.16B |
| 197 | ELVN | Enliven Therapeutics, Inc. | 3.53B | -5.00% | 617,772 | - |
| 198 | PRVA | Privia Health Group, Inc. | 3.52B | -0.71% | 1,340,200 | 2.25B |
| 199 | NHC | National HealthCare Corporation | 3.50B | 3.80% | 90,810 | 1.53B |
| 200 | OPCH | Option Care Health, Inc. | 3.49B | 0.59% | 1,095,249 | 5.67B |
| 201 | ADPT | Adaptive Biotechnologies Corporation | 3.45B | -5.85% | 1,511,572 | 295.41M |
| 202 | ALMS | Alumis Inc. | 3.45B | -6.14% | 486,476 | 8.40M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.44B | -1.01% | 689,748 | 415.62M |
| 204 | IDYA | IDEAYA Biosciences, Inc. | 3.43B | -1.88% | 305,639 | 225.27M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.36B | -4.68% | 698,538 | 236.00M |
| 206 | WRBY | Warby Parker Inc. | 3.35B | -2.33% | 1,632,647 | 890.57M |
| 207 | ITGR | Integer Holdings Corporation | 3.33B | 2.56% | 257,884 | 1.86B |
| 208 | GPCR | Structure Therapeutics Inc. | 3.30B | -6.43% | 404,967 | - |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 3.08B | 3.63% | 1,713,968 | 3.37B |
| 210 | GRAL | GRAIL, Inc. | 3.05B | -4.46% | 252,443 | 156.12M |
| 211 | RARE | Ultragenyx Pharmaceutical Inc. | 2.95B | -5.27% | 660,893 | 670.00M |
| 212 | IRON | Disc Medicine, Inc. | 2.83B | -2.42% | 230,808 | - |
| 213 | VERA | Vera Therapeutics, Inc. | 2.82B | -7.53% | 867,733 | - |
| 214 | BEAM | Beam Therapeutics Inc. | 2.81B | -8.43% | 3,246,363 | 164.01M |
| 215 | SUPN | Supernus Pharmaceuticals, Inc. | 2.78B | 0.50% | 213,844 | 776.83M |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.77B | -7.88% | 602,684 | 865.00K |
| 217 | XRAY | DENTSPLY SIRONA Inc. | 2.77B | 3.17% | 3,537,026 | 3.68B |
| 218 | MBX | MBX Biosciences, Inc. | 2.75B | -4.70% | 500,567 | - |
| 219 | QURE | uniQure N.V. | 2.73B | -3.22% | 774,593 | 18.09M |
| 220 | ESTA | Establishment Labs Holdings Inc. | 2.66B | -0.32% | 227,161 | 229.58M |
| 221 | TMDX | TransMedics Group, Inc. | 2.63B | 1.07% | 451,166 | 635.89M |
| 222 | ATAI | AtaiBeckley Inc. | 2.62B | 32.56% | 148,494,158 | 3.49M |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.55B | 0.83% | 106,404 | 1.46B |
| 224 | KOD | Kodiak Sciences Inc. | 2.55B | -3.89% | 275,048 | - |
| 225 | MESO | Mesoblast Limited | 2.52B | 0.69% | 546,158 | 65.38M |
| 226 | PGNY | Progyny, Inc. | 2.52B | -0.68% | 873,605 | 1.29B |
| 227 | TARS | Tarsus Pharmaceuticals, Inc. | 2.51B | 1.34% | 836,494 | 535.08M |
| 228 | IMNM | Immunome, Inc. | 2.49B | -4.19% | 491,495 | 4.02M |
| 229 | TRVI | Trevi Therapeutics, Inc. | 2.44B | -5.26% | 1,954,359 | - |
| 230 | VCEL | Vericel Corporation | 2.43B | 1.84% | 203,342 | 292.09M |
| 231 | PBH | Prestige Consumer Healthcare Inc. | 2.40B | 4.82% | 226,113 | 1.09B |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.38B | -3.73% | 458,277 | 36.77M |
| 233 | RGC | Regencell Bioscience Holdings Limited | 2.37B | -6.73% | 253,088 | - |
| 234 | KLRA | Kailera Therapeutics, Inc. | 2.35B | -6.06% | 214,662 | - |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.34B | -2.64% | 489,029 | - |
| 236 | LMAT | LeMaitre Vascular, Inc. | 2.34B | 2.76% | 131,170 | 256.28M |
| 237 | CLOV | Clover Health Investments, Corp. | 2.34B | -5.13% | 3,276,114 | 2.21B |
| 238 | PHVS | Pharvaris N.V. | 2.32B | -5.38% | 135,866 | - |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.32B | -2.82% | 2,009,980 | 885.72M |
| 240 | ZLAB | Zai Lab Limited | 2.32B | 1.08% | 498,715 | 453.28M |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.30B | -3.11% | 384,247 | 66.05M |
| 242 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -8.84% | 7,358,118 | - |
| 243 | ASTH | Astrana Health, Inc. | 2.28B | -2.21% | 269,086 | 3.53B |
| 244 | HTFL | HeartFlow, Inc. | 2.26B | -4.00% | 615,862 | 191.42M |
| 245 | NEOG | Neogen Corporation | 2.24B | 3.26% | 1,056,869 | 870.56M |
| 246 | NKTR | Nektar Therapeutics | 2.24B | -2.89% | 340,976 | 55.63M |
| 247 | SGRY | Surgery Partners, Inc. | 2.15B | 4.59% | 692,950 | 3.34B |
| 248 | AVAH | Aveanna Healthcare Holdings Inc. | 2.14B | 2.50% | 1,903,423 | 2.52B |
| 249 | OMCL | Omnicell, Inc. | 2.14B | 0.62% | 227,706 | 1.23B |
| 250 | BHVN | Biohaven Ltd. | 2.13B | -4.58% | 674,422 | - |
| 251 | IOVA | Iovance Biotherapeutics, Inc. | 2.13B | 0.84% | 22,710,790 | 285.61M |
| 252 | MD | Pediatrix Medical Group, Inc. | 2.13B | 2.55% | 495,909 | 1.93B |
| 253 | AXGN | Axogen, Inc. | 2.10B | 2.20% | 671,122 | 238.11M |
| 254 | PVLA | Palvella Therapeutics, Inc. | 2.09B | -3.93% | 170,938 | - |
| 255 | ADUS | Addus HomeCare Corporation | 2.08B | 3.03% | 179,266 | 1.45B |
| 256 | COAG | Hemab Therapeutics Holdings, Inc. | 2.07B | 2.12% | 280,027 | - |
| 257 | AGL | agilon health, inc. | 2.05B | -1.36% | 356,930 | 5.82B |
| 258 | ADMA | ADMA Biologics, Inc. | 2.04B | 1.61% | 1,273,228 | 509.86M |
| 259 | HCM | HUTCHMED (China) Limited | 2.04B | - | 23,437 | 548.51M |
| 260 | SNDX | Syndax Pharmaceuticals, Inc. | 2.03B | -2.38% | 962,658 | 217.17M |
| 261 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -1.80% | 418,557 | 298.30M |
| 262 | NBTX | Nanobiotix S.A. | 2.02B | -7.51% | 122,573 | 38.27M |
| 263 | SION | Sionna Therapeutics, Inc. | 2.01B | 0.14% | 681,954 | - |
| 264 | NUVB | Nuvation Bio Inc. | 1.99B | -3.22% | 2,702,570 | 143.05M |
| 265 | CDNA | CareDx, Inc. | 1.97B | 28.44% | 3,425,911 | 412.82M |
| 266 | OCUL | Ocular Therapeutix, Inc. | 1.97B | -9.74% | 1,727,339 | 52.04M |
| 267 | VRDN | Viridian Therapeutics, Inc. | 1.97B | -6.56% | 1,391,824 | 70.92M |
| 268 | GHRS | GH Research PLC | 1.96B | 6.20% | 1,264,851 | - |
| 269 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 0.70% | 119,125 | 1.20B |
| 270 | UFPT | UFP Technologies, Inc. | 1.96B | 2.80% | 161,443 | 608.85M |
| 271 | URGN | UroGen Pharma Ltd. | 1.95B | 0.80% | 783,037 | 140.49M |
| 272 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | -4.53% | 998,244 | 899.11M |
| 273 | GLUE | Monte Rosa Therapeutics, Inc. | 1.92B | -2.88% | 798,730 | 42.95M |
| 274 | NEO | NeoGenomics, Inc. | 1.90B | 0.55% | 2,673,314 | 745.97M |
| 275 | TSHA | Taysha Gene Therapies, Inc. | 1.89B | -4.52% | 1,624,894 | 7.47M |
| 276 | RAPP | Rapport Therapeutics, Inc. | 1.89B | -1.05% | 164,443 | 20.00M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.88B | 2.58% | 270,196 | 367.34M |
| 278 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.87B | -5.23% | 580,064 | -665.00K |
| 279 | TYRA | Tyra Biosciences, Inc. | 1.87B | -3.06% | 252,080 | - |
| 280 | DMRA | Damora Therapeutics, Inc. | 1.87B | -2.04% | 187,676 | - |
| 281 | NVCR | NovoCure Limited | 1.86B | 0.37% | 570,734 | 674.41M |
| 282 | ABCL | AbCellera Biologics Inc. | 1.86B | -9.79% | 6,321,636 | 79.21M |
| 283 | AAPG | Ascentage Pharma Group International | 1.85B | -0.07% | 1,379 | 82.08M |
| 284 | KARD | Kardigan, Inc. | 1.85B | -6.00% | 254,276 | - |
| 285 | PLSE | Pulse Biosciences, Inc. | 1.84B | 1.22% | 78,546 | 751.00K |
| 286 | BHC | Bausch Health Companies Inc. | 1.83B | 0.41% | 1,032,637 | 10.53B |
| 287 | WGS | GeneDx Holdings Corp. | 1.83B | -6.70% | 454,804 | 442.68M |
| 288 | BFLY | Butterfly Network, Inc. | 1.83B | -4.11% | 7,872,621 | 102.92M |
| 289 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -1.99% | 1,880,469 | 2.18B |
| 290 | ATRC | AtriCure, Inc. | 1.81B | 3.34% | 384,699 | 552.16M |
| 291 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.80B | -1.14% | 3,503,123 | 204.73M |
| 292 | STOK | Stoke Therapeutics, Inc. | 1.79B | -3.74% | 274,782 | 32.08M |
| 293 | BCAX | Bicara Therapeutics Inc. | 1.78B | -3.40% | 251,743 | - |
| 294 | PGEN | Precigen, Inc. | 1.76B | -3.81% | 2,437,530 | 31.60M |
| 295 | ZBIO | Zenas BioPharma, Inc. | 1.75B | -5.68% | 486,923 | 10.00M |
| 296 | GENB | Generate Biomedicines, Inc. | 1.75B | -3.02% | 247,258 | 30.30M |
| 297 | ZYME | Zymeworks Inc. | 1.73B | -1.78% | 178,220 | 81.26M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | 1.01% | 128,134 | 923.71M |
| 299 | IMCR | Immunocore Holdings plc | 1.72B | -2.34% | 613,340 | 412.81M |
| 300 | TDOC | Teladoc Health, Inc. | 1.71B | -2.47% | 2,085,714 | 2.51B |
| 301 | HCSG | Healthcare Services Group, Inc. | 1.71B | 2.18% | 360,125 | 1.85B |
| 302 | ALMR | Alamar Biosciences, Inc. | 1.70B | -5.93% | 320,437 | 87.16M |
| 303 | FTRE | Fortrea Holdings Inc. | 1.69B | -0.06% | 368,252 | 2.71B |
| 304 | CMPS | COMPASS Pathways plc | 1.67B | -6.80% | 10,378,357 | - |
| 305 | HROW | Harrow, Inc. | 1.67B | 4.22% | 618,772 | 268.68M |
| 306 | MPLT | MapLight Therapeutics, Inc. | 1.65B | -2.29% | 536,334 | - |
| 307 | NTLA | Intellia Therapeutics, Inc. | 1.64B | -10.01% | 4,806,196 | 66.09M |
| 308 | INVA | Innoviva, Inc. | 1.63B | 0.59% | 350,410 | 420.69M |
| 309 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | -7.85% | 23,788,674 | 66.41M |
| 310 | ANAB | AnaptysBio, Inc. | 1.61B | -2.60% | 434,188 | 232.39M |
| 311 | INNV | InnovAge Holding Corp. | 1.61B | 2.33% | 297,761 | 949.17M |
| 312 | VIR | Vir Biotechnology, Inc. | 1.59B | -2.19% | 1,340,516 | 65.50M |
| 313 | ENOV | Enovis Corporation | 1.59B | 7.62% | 700,299 | 2.28B |
| 314 | TRLV | Trulieve Cannabis Corp. | 1.58B | -4.52% | 650,310 | 1.17B |
| 315 | MLTX | MoonLake Immunotherapeutics | 1.57B | -4.51% | 922,414 | - |
| 316 | PSNL | Personalis, Inc. | 1.54B | -6.90% | 3,460,564 | 64.52M |
| 317 | IART | Integra LifeSciences Holdings Corporation | 1.53B | 4.85% | 575,508 | 1.64B |
| 318 | PRGO | Perrigo Company plc | 1.52B | 8.37% | 1,996,480 | 4.18B |
| 319 | XERS | Xeris Biopharma Holdings, Inc. | 1.50B | -0.34% | 898,867 | 314.85M |
| 320 | MAZE | Maze Therapeutics, Inc. | 1.50B | -8.03% | 442,827 | 20.00M |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -2.70% | 300,641 | - |
| 322 | INSP | Inspire Medical Systems, Inc. | 1.49B | 2.44% | 400,999 | 915.25M |
| 323 | PNTG | The Pennant Group, Inc. | 1.46B | 4.87% | 200,460 | 1.02B |
| 324 | BLFS | BioLife Solutions, Inc. | 1.46B | 2.20% | 544,723 | 101.66M |
| 325 | STAA | STAAR Surgical Company | 1.45B | 2.46% | 256,311 | 290.38M |
| 326 | ARDT | Ardent Health, Inc. | 1.45B | 3.16% | 305,665 | 6.43B |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.45B | 0.18% | 409,066 | 95.13M |
| 328 | AHCO | AdaptHealth Corp. | 1.44B | 2.36% | 568,749 | 3.29B |
| 329 | ATEC | Alphatec Holdings, Inc. | 1.44B | 3.26% | 1,167,793 | 787.08M |
| 330 | SEPN | Septerna, Inc. | 1.43B | -6.77% | 224,402 | 72.26M |
| 331 | AKTS | Aktis Oncology, Inc. | 1.42B | -1.27% | 232,093 | 8.28M |
| 332 | OMDA | Omada Health, Inc. | 1.40B | -0.51% | 860,298 | 283.30M |
| 333 | SVRA | Savara Inc. | 1.40B | -5.08% | 671,625 | - |
| 334 | PAHC | Phibro Animal Health Corporation | 1.39B | 1.78% | 183,076 | 1.50B |
| 335 | ABSI | Absci Corporation | 1.39B | -16.03% | 5,149,275 | 1.84M |
| 336 | CNMD | CONMED Corporation | 1.36B | 5.28% | 405,630 | 1.37B |
| 337 | NVAX | Novavax, Inc. | 1.35B | -2.61% | 1,493,990 | 596.34M |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.34B | 6.58% | 428,069 | 3.42B |
| 339 | AHG | Akso Health Group | 1.32B | 0.33% | 2,999 | 14.84M |
| 340 | INBX | Inhibrx Biosciences, Inc. | 1.29B | -3.65% | 205,457 | 1.30M |
| 341 | IMTX | Immatics N.V. | 1.27B | -2.11% | 218,104 | 43.00M |
| 342 | MNKD | MannKind Corporation | 1.26B | -0.61% | 1,773,692 | 360.78M |
| 343 | ARDX | Ardelyx, Inc. | 1.25B | -4.15% | 1,291,026 | 427.68M |
| 344 | AORT | Artivion, Inc. | 1.25B | 6.17% | 539,547 | 458.69M |
| 345 | QDEL | QuidelOrtho Corporation | 1.25B | 0.22% | 601,751 | 2.66B |
| 346 | IRMD | IRADIMED CORPORATION | 1.24B | 3.67% | 66,893 | 86.28M |
| 347 | TRAX | First Tracks Biotherapeutics, Inc. | 1.23B | -2.68% | 510,662 | - |
| 348 | JBIO | Jade Biosciences, Inc. | 1.22B | -5.90% | 754,896 | - |
| 349 | AZTA | Azenta, Inc. | 1.21B | -1.35% | 295,167 | 596.48M |
| 350 | ALVO | Alvotech | 1.20B | -0.59% | 179,606 | 562.04M |
| 351 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -5.09% | 710,196 | - |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.19B | -0.38% | 236,829 | 796.33M |
| 353 | SDGR | Schrödinger, Inc. | 1.18B | -3.07% | 858,922 | 254.91M |
| 354 | AVNS | Avanos Medical, Inc. | 1.17B | 0.02% | 184,108 | 715.90M |
| 355 | NUTX | Nutex Health Inc. | 1.14B | -5.93% | 97,208 | 879.95M |
| 356 | AVLN | Avalyn Pharma Inc. | 1.13B | -6.82% | 143,460 | - |
| 357 | CERT | Certara, Inc. | 1.13B | 2.83% | 2,139,559 | 419.75M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.13B | -3.03% | 308,242 | 79.76M |
| 359 | USPH | U.S. Physical Therapy, Inc. | 1.12B | 3.36% | 280,843 | 787.69M |
| 360 | TNDM | Tandem Diabetes Care, Inc. | 1.11B | 6.48% | 1,030,226 | 1.03B |
| 361 | CAPR | Capricor Therapeutics, Inc. | 1.10B | -6.24% | 909,296 | 11.13M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.10B | 0.52% | 918,302 | 322.02M |
| 363 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | -5.57% | 686,356 | - |
| 364 | XNCR | Xencor, Inc. | 1.09B | -2.30% | 214,551 | 97.36M |
| 365 | EYPT | EyePoint, Inc. | 1.08B | -6.71% | 1,142,379 | 7.61M |
| 366 | WVE | Wave Life Sciences Ltd. | 1.08B | -4.91% | 1,541,993 | 71.80M |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | 1.81% | 134,609 | 1.03B |
| 368 | DRTS | Alpha Tau Medical Ltd. | 1.07B | -4.86% | 514,862 | - |
| 369 | GDRX | GoodRx Holdings, Inc. | 1.05B | 1.31% | 811,664 | 787.89M |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.05B | -3.11% | 353,012 | - |
| 371 | GMRS | GMR Solutions Inc. | 1.05B | -3.86% | 232,790 | 5.83B |
| 372 | SPTX | Seaport Therapeutics, Inc. | 1.05B | -4.50% | 43,765 | - |
| 373 | FBRX | Forte Biosciences, Inc. | 1.04B | -3.87% | 490,884 | - |
| 374 | IVA | Inventiva S.A. | 1.03B | 2.24% | 729,696 | 7.94M |
| 375 | CRON | Cronos Group Inc. | 1.03B | 1.64% | 724,671 | 159.54M |
| 376 | BVS | Bioventus Inc. | 1.03B | 2.88% | 359,605 | 576.30M |
| 377 | ETON | Eton Pharmaceuticals, Inc. | 1.03B | -2.60% | 278,264 | 86.93M |
| 378 | PCRX | Pacira BioSciences, Inc. | 1.01B | 1.72% | 451,345 | 734.86M |
| 379 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | -7.52% | 498,338 | - |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 981.67M | 0.45% | 1,837,379 | 69.64M |
| 381 | ANNX | Annexon, Inc. | 971.59M | -8.77% | 6,219,768 | - |
| 382 | BIOA | BioAge Labs, Inc. | 969.51M | -3.92% | 279,791 | 10.32M |
| 383 | JANX | Janux Therapeutics, Inc. | 964.77M | -1.31% | 393,125 | 13.73M |
| 384 | KURA | Kura Oncology, Inc. | 957.88M | -4.77% | 564,611 | 71.64M |
| 385 | OLMA | Olema Pharmaceuticals, Inc. | 957.33M | -7.28% | 669,392 | - |
| 386 | SANA | Sana Biotechnology, Inc. | 953.68M | -10.42% | 2,080,630 | - |
| 387 | AVTX | Avalo Therapeutics, Inc. | 948.55M | -2.72% | 755,863 | 59.00K |
| 388 | PHAR | Pharming Group N.V. | 936.04M | -2.07% | 3,128 | 369.49M |
| 389 | DBVT | DBV Technologies S.A. | 935.50M | -2.55% | 234,053 | 5.74M |
| 390 | VOR | Vor Biopharma Inc. | 929.29M | -5.14% | 594,490 | - |
| 391 | ABUS | Arbutus Biopharma Corporation | 926.45M | 2.85% | 1,717,349 | 191.45M |
| 392 | GERN | Geron Corporation | 904.54M | -0.70% | 4,366,686 | 196.12M |
| 393 | OPK | OPKO Health, Inc. | 898.56M | -0.83% | 2,731,898 | 581.12M |
| 394 | INMD | InMode Ltd. | 895.26M | 1.93% | 718,538 | 374.64M |
| 395 | GLAS | Glass House Brands Inc. | 886.48M | -5.44% | 470,881 | 177.68M |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 885.83M | 3.56% | 211,611 | 720.53M |
| 397 | SLDB | Solid Biosciences Inc. | 882.11M | -6.86% | 553,323 | - |
| 398 | TBPH | Theravance Biopharma, Inc. | 880.04M | 0.30% | 145,880 | 109.78M |
| 399 | LBRX | LB Pharmaceuticals Inc | 875.50M | -5.07% | 127,334 | - |
| 400 | TALK | Talkspace, Inc. | 873.58M | 0.10% | 1,107,922 | 238.37M |
| 401 | PHAT | Phathom Pharmaceuticals, Inc. | 872.14M | -0.63% | 234,897 | 204.89M |
| 402 | HSTM | HealthStream, Inc. | 844.61M | 2.34% | 73,643 | 311.78M |
| 403 | ODTX | Odyssey Therapeutics, Inc. | 802.44M | -2.84% | 712,994 | 1.06M |
| 404 | SIBN | SI-BONE, Inc. | 800.95M | 4.70% | 350,035 | 206.22M |
| 405 | AVR | Anteris Technologies Global Corp. | 795.85M | -5.98% | 1,098,232 | 1.85M |
| 406 | REPL | Replimune Group, Inc. | 782.37M | -3.72% | 2,460,406 | - |
| 407 | DSGN | Design Therapeutics, Inc. | 777.59M | -7.91% | 505,580 | - |
| 408 | CTMX | CytomX Therapeutics, Inc. | 775.02M | -3.26% | 1,793,665 | 35.54M |
| 409 | RIGL | Rigel Pharmaceuticals, Inc. | 772.83M | 1.43% | 223,152 | 299.77M |
| 410 | OCS | Oculis Holding AG | 759.68M | -4.12% | 219,459 | 1.40M |
| 411 | BBNX | Beta Bionics, Inc. | 754.88M | 0.47% | 480,588 | 110.24M |
| 412 | SPRY | ARS Pharmaceuticals, Inc. | 754.70M | 0.66% | 820,492 | 98.99M |
| 413 | AURA | Aura Biosciences, Inc. | 753.35M | -2.57% | 178,054 | - |
| 414 | TENX | Tenax Therapeutics, Inc. | 752.58M | -3.98% | 558,311 | - |
| 415 | ZVRA | Zevra Therapeutics, Inc. | 751.35M | -1.93% | 588,282 | 122.29M |
| 416 | DRUG | Bright Minds Biosciences Inc. | 741.29M | -3.16% | 308,825 | - |
| 417 | CSTL | Castle Biosciences, Inc. | 740.05M | 1.58% | 160,738 | 339.92M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 738.82M | -5.54% | 1,459,714 | 8.37M |
| 419 | NGNE | Neurogene Inc. | 729.42M | -7.21% | 102,230 | 925.00K |
| 420 | MNPR | Monopar Therapeutics Inc. | 727.69M | -0.06% | 131,970 | - |
| 421 | CBLL | CeriBell, Inc. | 723.95M | -1.65% | 418,189 | 95.07M |
| 422 | IMMX | Immix Biopharma, Inc. | 714.04M | -4.75% | 922,631 | - |
| 423 | GYRE | Gyre Therapeutics, Inc. | 713.53M | -2.44% | 20,765 | 117.05M |
| 424 | SSII | SS Innovations International, Inc. | 708.47M | 0.57% | 27,429 | 48.47M |
| 425 | SLBT | SL Science Holding Limited | 706.30M | 3.07% | 25,318 | - |
| 426 | EVO | Evotec SE | 704.00M | -1.24% | 53,064 | 859.03M |
| 427 | CLYM | Climb Bio, Inc. | 692.28M | -12.83% | 962,613 | - |
| 428 | SGP | SpyGlass Pharma, Inc. | 687.39M | -0.19% | 87,632 | - |
| 429 | CADL | Candel Therapeutics, Inc. | 684.34M | -3.11% | 648,267 | - |
| 430 | PHR | Phreesia, Inc. | 673.13M | 1.21% | 291,493 | 495.59M |
| 431 | OMER | Omeros Corporation | 671.64M | -10.51% | 1,627,201 | 9.89M |
| 432 | FTH | Faeth Therapeutics, Inc. | 668.53M | -17.59% | 607,885 | - |
| 433 | TCMD | Tactile Systems Technology, Inc. | 665.86M | 3.22% | 128,237 | 343.52M |
| 434 | EVH | Evolent Health, Inc. | 654.64M | -0.85% | 1,206,741 | 1.89B |
| 435 | MDXG | MiMedx Group, Inc. | 653.87M | 2.81% | 587,453 | 389.42M |
| 436 | CRMD | CorMedix Inc. | 653.50M | -1.07% | 521,498 | 400.05M |
| 437 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 652.47M | -3.15% | 182,293 | - |
| 438 | CERS | Cerus Corporation | 635.17M | -0.31% | 1,204,823 | 216.56M |
| 439 | IRWD | Ironwood Pharmaceuticals, Inc. | 632.12M | -4.00% | 1,286,211 | 361.51M |
| 440 | ALLO | Allogene Therapeutics, Inc. | 609.20M | -7.11% | 4,833,029 | 22.00K |
| 441 | ACHV | Achieve Life Sciences, Inc. | 600.56M | -7.58% | 1,343,910 | - |
| 442 | BWAY | BrainsWay Ltd. | 600.40M | -0.47% | 61,956 | 56.22M |
| 443 | CTKB | Cytek Biosciences, Inc. | 595.35M | -0.86% | 443,039 | 204.17M |
| 444 | AGMB | AgomAb Therapeutics NV | 594.92M | -4.35% | 59,657 | - |
| 445 | ANGO | AngioDynamics, Inc. | 586.09M | -2.00% | 777,775 | 320.17M |
| 446 | FLGT | Fulgent Genetics, Inc. | 585.90M | -1.81% | 119,389 | 320.35M |
| 447 | TECX | Tectonic Therapeutic, Inc. | 583.62M | -4.83% | 107,123 | - |
| 448 | NVCT | Nuvectis Pharma, Inc. | 583.54M | -5.51% | 222,642 | - |
| 449 | RLMD | Relmada Therapeutics, Inc. | 583.19M | -10.47% | 1,374,593 | - |
| 450 | WEAV | Weave Communications, Inc. | 582.82M | -0.34% | 568,398 | 248.72M |
| 451 | MYGN | Myriad Genetics, Inc. | 581.33M | -2.46% | 558,868 | 829.00M |
| 452 | PRME | Prime Medicine, Inc. | 574.36M | -8.88% | 2,464,134 | 4.03M |
| 453 | RGNX | REGENXBIO Inc. | 570.76M | -10.02% | 1,125,462 | 87.82M |
| 454 | FDMT | 4D Molecular Therapeutics, Inc. | 565.11M | -7.45% | 517,267 | 88.24M |
| 455 | NPCE | NeuroPace, Inc. | 563.40M | 1.94% | 49,068 | 99.53M |
| 456 | ALT | Altimmune, Inc. | 548.42M | -5.37% | 1,944,877 | 36.00K |
| 457 | DNA | Ginkgo Bioworks Holdings, Inc. | 539.25M | -8.28% | 832,546 | 151.40M |
| 458 | STTK | Shattuck Labs, Inc. | 532.93M | 2.66% | 1,246,450 | 1.00M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 530.02M | -0.51% | 177,114 | - |
| 460 | TOI | The Oncology Institute, Inc. | 529.91M | -6.36% | 1,642,827 | 545.76M |
| 461 | KIDS | OrthoPediatrics Corp. | 526.29M | 3.90% | 92,363 | 243.30M |
| 462 | CTEV | Claritev Corporation | 523.37M | 4.28% | 95,227 | 978.76M |
| 463 | TLRY | Tilray Brands, Inc. | 517.69M | -0.91% | 2,374,123 | 858.28M |
| 464 | ARVN | Arvinas, Inc. | 515.52M | -3.50% | 423,784 | 89.40M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 515.18M | -5.81% | 134,109 | - |
| 466 | ASMB | Assembly Biosciences, Inc. | 512.47M | -3.25% | 270,711 | 71.10M |
| 467 | CBIO | Crescent Biopharma, Inc. | 508.40M | -2.36% | 514,780 | 11.88M |
| 468 | NRC | NRC Health | 504.82M | 3.42% | 29,974 | 138.64M |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 470 | AQST | Aquestive Therapeutics, Inc. | 496.85M | 0.25% | 1,533,175 | 50.27M |
| 471 | VSTM | Verastem, Inc. | 493.85M | -1.92% | 1,220,582 | 49.59M |
| 472 | SLN | Silence Therapeutics plc | 492.65M | -0.19% | 408,834 | 839.00K |
| 473 | ZURA | Zura Bio Limited | 491.61M | -3.99% | 411,456 | - |
| 474 | SOPH | SOPHiA GENETICS SA | 489.11M | 1.04% | 225,434 | 81.18M |
| 475 | OFIX | Orthofix Medical Inc. | 476.57M | 4.43% | 102,737 | 825.37M |
| 476 | PROK | ProKidney Corp. | 474.23M | -1.88% | 811,992 | 889.00K |
| 477 | SGMT | Sagimet Biosciences Inc. | 473.02M | -4.13% | 556,814 | - |
| 478 | VALN | Valneva SE | 472.22M | -0.10% | 68,920 | 180.25M |
| 479 | VMD | Viemed Healthcare, Inc. | 468.86M | 2.95% | 318,826 | 286.57M |
| 480 | SI | Shoulder Innovations, Inc. | 463.08M | 2.34% | 59,873 | 53.89M |
| 481 | OCGN | Ocugen, Inc. | 460.39M | -4.90% | 3,631,868 | 4.47M |
| 482 | VREX | Varex Imaging Corporation | 458.55M | 0.83% | 117,974 | 857.50M |
| 483 | CLPT | ClearPoint Neuro, Inc. | 457.94M | -2.55% | 389,941 | 40.61M |
| 484 | ANL | Adlai Nortye Ltd. | 457.60M | 7.62% | 170,418 | 5.00M |
| 485 | PACB | Pacific Biosciences of California, Inc. | 456.58M | -3.92% | 3,205,589 | 160.03M |
| 486 | RZLT | Rezolute, Inc. | 456.52M | -7.81% | 576,242 | - |
| 487 | CYH | Community Health Systems, Inc. | 455.12M | 4.35% | 1,224,847 | 12.29B |
| 488 | SRTA | Strata Critical Medical, Inc. | 453.40M | -3.32% | 608,585 | 228.58M |
| 489 | NNNN | Anbio Biotechnology | 447.25M | 11.73% | 22,923 | 8.65M |
| 490 | OVID | Ovid Therapeutics Inc. | 447.00M | -3.82% | 824,289 | 7.12M |
| 491 | KYTX | Kyverna Therapeutics, Inc. | 444.41M | -6.04% | 1,350,415 | - |
| 492 | DCTH | Delcath Systems, Inc. | 440.84M | -3.11% | 257,677 | 90.44M |
| 493 | ARTV | Artiva Biotherapeutics, Inc. | 439.72M | -8.77% | 481,851 | 251.00K |
| 494 | HELP | Cybin Inc. | 437.30M | 8.37% | 3,272,926 | - |
| 495 | PRTA | Prothena Corporation plc | 434.53M | -1.54% | 438,800 | 57.94M |
| 496 | EDIT | Editas Medicine, Inc. | 434.30M | -6.91% | 1,027,974 | 38.69M |
| 497 | BNTC | Benitec Biopharma Inc. | 433.21M | -3.15% | 21,103 | - |
| 498 | EVMN | Evommune, Inc. | 430.06M | -4.10% | 463,461 | 10.00M |
| 499 | PBYI | Puma Biotechnology, Inc. | 427.05M | -0.24% | 262,149 | 227.18M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.44M | -6.29% | 122,558 | - |